Annual report pursuant to Section 13 and 15(d)

Equity-Based Compensation

v3.25.0.1
Equity-Based Compensation
12 Months Ended
Dec. 31, 2024
Tanger Factory Outlet Centers, Inc. [Member]  
Equity-Based Compensation Equity-Based Compensation
When a common share is issued by the Company, the Operating Partnership issues one corresponding unit of partnership interest to the Company's wholly-owned subsidiary, the Tanger LP Trust. Therefore, when the Company grants an equity based award, the Operating Partnership treats each award as having been granted by the Operating Partnership. In the discussion below, the term "we" refers to the Company and the Operating Partnership together and the term "shares" is meant to also include corresponding units of the Operating Partnership.

We have a shareholder approved equity-based compensation plan, the Incentive Award Plan of Tanger Inc. and Tanger Properties Limited Partnership, as amended (the “Plan”), which covers our non-employee directors, officers, employees and consultants. Effective May 19, 2023, the Plan was amended and restated to, among other things, increase the number of shares authorized for issuance under the plan to 21.3 million shares and extend the term of the plan by an additional ten years. As of December 31, 2024, common shares remaining available for future issuance totaled approximately 3.7 million common shares. The amount and terms of the awards granted under the Plan are determined by the Board (or the Compensation Committee of the Board).

We recorded equity-based compensation expense in general and administrative expenses in the consolidated statements of operations for the years ended December 31, 2024, 2023 and 2022, respectively, as follows (in thousands):
2024 2023 2022
Restricted common shares $ 7,385  $ 7,598  $ 7,654 
Notional unit performance awards 4,257  4,437  4,987 
Options 347  476  328 
Total equity-based compensation $ 11,989  $ 12,511  $ 12,969 

Equity-based compensation expense capitalized as a part of rental property and deferred lease costs were as follows (in thousands):
  2024 2023 2022
Equity-based compensation expense capitalized $ 130  $ 255  $ 191 

As of December 31, 2024, there was $15.1 million of total unrecognized compensation cost related to unvested common equity-based compensation arrangements granted under the Plan. That cost is expected to be recognized over a weighted-average period of 2.3 years.

Restricted Common Share and Restricted Share Unit Awards

During the years ended 2024, 2023 and 2022, the Company granted approximately 254,000, 345,000 and 513,000 restricted common shares and restricted share units, respectively, to the Company's non-employee directors and the Company's senior executive officers. The non-employee directors' restricted common shares generally vest ratably over periods ranging from one to three year periods and the senior executive officers' restricted common shares generally vest ratably over three years. Compensation expense related to the amortization of the deferred compensation is being recognized in accordance with the vesting schedule of the restricted common shares and restricted share units. For all of the restricted common share and restricted share unit awards described above, the grant date fair value of the awards were determined based upon the closing market price of the Company's common shares on the day prior to the grant date.
The following table summarizes information related to unvested restricted common shares and restricted share units outstanding for the years ended December 31, 2024, 2023 and 2022:

Unvested Restricted Common Shares and Restricted Share Units Number of shares and units Weighted average grant date fair value
Outstanding at December 31, 2021
1,029,805  $ 13.51 
Granted (1)
512,957  17.32 
Vested (545,788) 14.01 
Forfeited (26,591) 15.87 
Outstanding at December 31, 2022
970,383  $ 15.18 
Granted (2)
345,297  17.85 
Vested (480,036) 13.21 
Forfeited (31,803) 15.89 
Outstanding at December 31, 2023
803,841  $ 17.47 
Granted 254,019  26.82 
Vested (499,704) 17.07 
Forfeited (14,553) 21.53 
Outstanding at December 31, 2024
543,603  $ 22.00 
(1)Includes 36,102 restricted share units.
(2)Includes 22,819 restricted share units.

The table above excludes restricted common shares earned under the 2019, 2020 and 2021 Performance Share Plans. In connection with the 2019 Performance Share Plan, we issued approximately 97,000 restricted common shares in February 2022, with approximately 59,000 vesting during 2022 and the remaining 38,000 vesting in February 2023. In connection with the 2020 Performance Share Plan, we issued approximately 759,000 restricted common shares in February 2023, with approximately 444,000 vesting during 2023 and the remaining 315,000 vesting in February 2024. In connection with the 2021 Performance Share Plan, we issued approximately 479,000 restricted common shares in February 2024, with approximately 344,000 vesting during 2024 and the remaining 135,000 to vest in February 2025. All performance share plan vesting is contingent upon continued employment with the Company through the vesting date (unless terminated prior thereto (a) by the Company without cause, (b) by participant for good reason, (c) due to death or disability or (d) in certain cases, due to retirement).

The total value of restricted common shares vested during the years ended 2024, 2023 and 2022 was $32.0 million, $18.2 million and $10.6 million, respectively. During the years ended 2024, 2023 and 2022, we withheld shares with value equivalent to the employees' obligation for the applicable income and other employment taxes, and remitted the cash to the appropriate taxing authorities. The total number of shares withheld were approximately 420,000, 380,000 and 240,000 for the years ended 2024, 2023 and 2022, respectively, and were based on the value of the restricted common shares on the vesting date as determined by our closing share price on the day prior to the vesting date. Total amounts paid for the employees' tax obligation to taxing authorities were $12.0 million, $7.3 million and $3.7 million for the years ended 2024, 2023 and 2022, respectively, which are reflected as a financing activity within the consolidated statements of cash flows.
Notional Unit Performance Awards

Performance Share Plan

Each year, the Compensation Committee of the Company approves the terms and the number of awards to be granted under the Tanger Inc. Performance Share Plan (the “PSP"), formerly titled the "Outperformance Plan". The PSP is a long-term incentive compensation plan. Recipients may earn units that may convert, subject to the achievement of the goals described below, into restricted common shares of the Company based on the Company’s absolute share price appreciation (or absolute total shareholder return) and its share price appreciation relative to its peer group (or relative total shareholder return) over a three-year measurement period. For all recipients, any shares earned at the end of the three-year measurement period are subject to a time-based vesting schedule, with 50% of the shares vesting immediately following the measurement period, and the remaining 50% vesting one year thereafter, contingent upon continued employment with the Company through the vesting date (unless terminated prior thereto (a) by the Company without cause, (b) by participant for good reason, (c) due to death or disability or (d) in certain cases, due to retirement).

The following table sets forth PSP performance targets and other relevant information about each plan:
2024
PSP (1)
2023
PSP(1)
2022
PSP(1)
2021
PSP(1)
Performance targets
Absolute portion of award:
Percent of total award 33% 33% 33% 33%
Absolute total shareholder return range 26  % - 41% 26  % - 41% 26  % - 41% 26  % - 41%
Percentage of units to be earned 20  % - 100% 20  % - 100% 20  % - 100% 20  % - 100%
Relative portion of award:
Percent of total award 67% 67% 67% 67%
Percentile rank of peer group range 30th - 80th 30  th - 80th 30  th - 80th 30  th - 80th
Percentage of units to be earned 20% - 100% 20% - 100% 20% - 100% 20% - 100%
Maximum number of restricted common shares that may be earned 367,126 499,696 555,349 688,824
Grant date fair value per share $16.36 $12.08 $11.68 $9.65
August 2021 grant date fair value per share (2)
N/A N/A N/A $12.44
(1)The number of restricted common shares received under the 2024, 2023, 2022 and 2021 PSP will be determined on a pro-rata basis by linear interpolation between total shareholder return thresholds, both for absolute total shareholder return and for relative total shareholder return amongst the Company's peer group. The peer group is based on companies included in the FTSE Nareit Equity Retail Index.
(2)In August of 2021, additional awards under the 2021 PSP were granted to recently hired senior executive officers whereby a maximum of approximately 26,000 restricted common shares may be earned.

The fair values of the PSP awards granted during the years ended December 31, 2024, 2023 and 2022 were determined at the grant dates using a Monte Carlo simulation pricing model and the following assumptions:
PSP PSP PSP
2024 2023 2022
Risk free interest rate (1)
4.40  % 3.90  % 1.70  %
Expected dividend yield (2)
4.3  % 4.6  % 5.7  %
Expected volatility (3)
37  % 62  % 65  %
(1)Represents the interest rate as of the grant date on U.S. treasury bonds having the same life as the estimated life of the restricted unit grants.
(2)The dividend yield is calculated utilizing the dividends paid for the previous five-year period.
(3)Based on a mix of historical and implied volatility for our common shares and the common shares of our peer index companies over the measurement period.
The following table sets forth PSP activity for the years ended December 31, 2024, 2023 and 2022:
Unvested PSP Awards
Number of units Weighted average grant date fair value
Outstanding as of December 31, 2021
1,826,266  $ 8.82 
Awarded 556,794  11.68 
Earned (1)
(96,592) 12.42 
Forfeited (475,061) 11.44 
Outstanding as of December 31, 2022
1,811,407  $ 8.84 
Awarded 499,696  12.08 
Earned (1)
(758,814) 7.30 
Forfeited (149,948) 9.87 
Outstanding as of December 31, 2023
1,402,341  $ 10.29 
Awarded 367,126  16.36 
Earned (1)
(479,097) 9.76 
Forfeited (63,081) 12.18 
Outstanding as of December 31, 2024
1,227,289  $ 12.90 
(1)Represents the units under the 2019, 2020 and 2021 PSP that are no longer outstanding and have been settled in restricted common shares.
Option Awards

Options outstanding at December 31, 2024 had the following weighted average exercise prices and weighted average remaining contractual lives:
Options Outstanding Options Exercisable
Exercise prices Options Weighted average exercise price Weighted remaining contractual life in years Options Weighted average exercise price
$ 5.73  117,875  $ 5.73  5.69 75,075  $ 5.73 
$ 7.15  1,000,000  $ 7.15  5.37 1,000,000  $ 7.15 
$ 19.37  250,000  $ 19.37  7.91 —  $ — 
$ 21.94  66,935  $ 21.94  3.20 66,935  $ 21.94 
1,434,810  $ 9.85  5.74 1,142,010  $ 7.92 

A summary of option activity under the Plan for the years ended December 31, 2024, 2023 and 2022 (aggregate intrinsic value amount in thousands):
Options Shares Weighted-average exercise price Weighted-average remaining contractual life in years Aggregate intrinsic value
Outstanding as of December 31, 2021
1,595,600  $ 10.68  7.64 $ 15,707 
Granted 250,000  19.37 
Exercised (15,500) 5.73 
Forfeited (113,300) 17.66 
Outstanding as of December 31, 2022
1,716,800  $ 11.53  6.79 $ 13,275 
Granted —  — 
Exercised (85,500) 14.45 
Forfeited (26,300) 16.55 
Outstanding as of December 31, 2023
1,605,000  $ 11.30  6.31 $ 26,719 
Granted —  — 
Exercised (84,990) 15.47 
Forfeited (85,200) 31.43 
Outstanding as of December 31, 2024
1,434,810  $ 9.85  5.74 $ 34,834 
Vested and Expected to Vest as of
December 31, 2024
1,432,647  $ 9.86  5.74 $ 34,772 
Exercisable as of December 31, 2024
1,142,010  $ 7.92  5.26 $ 29,928 
In November 2022, Michael Bilerman became the Executive Vice President, Chief Financial Officer and Chief Investment Officer of the Company. Mr. Bilerman was granted 250,000 options that have an exercise price of $19.37 per share, which equaled the closing market price of a common share of the Company on the day prior to the grant date. The options expire 10 years from the date of grant and 60% of the options become exercisable on November 29, 2025, 20% of the options become exercisable on November 29, 2026 and 20% of the options become exercisable on November 29, 2027, in each case, contingent upon continued employment with the Company through the applicable vesting date (subject to acceleration upon certain terminations of employment). The fair value of each option grant was estimated on the date of grant using the Black-Scholes option pricing model, which resulted in a weighted average grant date fair value per share of $6.13 and included the following weighted-average assumptions: expected dividend yield of 5.10%; expected life of 6.8 years; expected volatility of 48%; a risk-free rate of 3.96%; and forfeiture rate of 0.0%.

401(k) Retirement Savings Plan
We have a 401(k) Retirement Savings Plan covering substantially all employees who meet certain age and employment criteria. An employee may invest pretax earnings in the 401(k) plan up to the maximum legal limits (as defined by Federal regulations). This plan allows participants to defer a portion of their compensation and to receive matching contributions for a portion of the deferred amounts. During the years ended December 31, 2024, 2023 and 2022, we contributed approximately $1.4 million, $1.2 million and $968,000, respectively, to the 401(k) Retirement Savings Plan.